Duvoglustat Hydrochloride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameDuvoglustat Hydrochloride
Drug Alias NameDuvoglustatum度鲁司他1-Deoxynojirimycin hydrochlorideDeoxynojirimycin hydrochlorideDuvoglustat-ERT combo therapy +[13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMaltase-glucoamylase stimulants
TargetsMaltase-glucoamylase
Therapy Area/IndicationsGlycogen Storage Disease Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUnited Kingdom +[4
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmicus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmicus Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsGlycogen Storage Disease Type II

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG